Researchers find quick way to make human monoclonal antibodies against flu

For more information on information about influenza, visit http://www3.niaid.nih.gov/healthscience/healthtopics/Flu/default.htm.

NIAID is a component of the NIH. NIAID supports basic and applied research to prevent, diagnose and treat infectious diseases such as HIV/AIDS and other sexually transmitted infections, influenza, tuberculosis, malaria and illness from potential agents of bioterrorism. NIAID also supports research on basic immunology, transplantation and immune-related disorders, including autoimmune diseases, asthma and allergies.

NCRR, also a component of NIH, provides laboratory scientists and clinical researchers with resources, tools and training they need to understand, detect, treat and prevent a wide range of diseases. NCRR also supports basic, translational and applied research on variety of diseases through resource building. The research highlighted here was supported, in part, by NCRR’s Institutional Development Awards Program, which helps build research infrastructure to enhance institutions’ research capacity and competitiveness for NIH grants.

The National Institutes of Health (NIH)--The Nation's Medical Research Agency--includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.

Reference: J Wrammert et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature DOI: 10.1038/nature06890 (2008).

News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at http://www.niaid.nih.gov.